Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre open-label randomised controlled trial

摘要

IntroductionThis randomised controlled trial aims to compare the efficacy of warfarin replacement with apixaban without postoperative resumption of heparin with that of conventional heparin bridging in patients taking warfarin and scheduled to undergo endoscopic mucosal resection (EMR): specifically, by checking for reduction in proportion of postoperative bleeding following EMR.